High transparencyReviewed June 1, 2026Source-verified pricing
Updated: June 1, 2026 · Editorial review: GLP-1 Price Guide Editorial Team · Pricing verified: June 1, 2026
Editorial disclosure: GLP-1 Price Guide is an educational health pricing resource. We do not provide medical advice, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Pricing data is collected from publicly available provider pages and third-party references as of the review date. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page.
NexLife is GLP-1 Price Guide's Editor's Pick #1 for transparent flat-rate pricing in our 2026 review. Lowest true 12-month cost for both compounded semaglutide ($1,740/year) and compounded tirzepatide ($2,232/year).
Availability varies by state. Operates through 50-state PC/foreign-qualification network.
Medical Director
Adam Kennah, M.D.
Trustpilot (verify)
4.7/5 (51 verified reviews as of June 1, 2026)
Strengths
Flat-rate pricing at every eligible dose
Six named partner pharmacies disclosed pre-purchase
LegitScript certified
Telehealth visits, shipping, and Care360 support included
Lowest transparent 12-month cost in our review
Four clear plan tiers (12-mo / 6-mo / 3-mo / m2m)
Trade-offs
12-month commitment required for $145/$186 rate
Compounded medication (not FDA-approved)
Smaller brand recognition than legacy telehealth
Pricing Transparency Analysis
NexLife's pricing transparency reflects our v1.0 methodology evaluation across four dimensions:
Dimension
NexLife's position
Advertised price
$145/mo (12-mo)
True monthly cost at maintenance
Same as advertised (flat-rate)
Dose escalation behavior
Flat-rate across eligible doses (no dose-tier escalation)
Hidden fees
Bundled (included in monthly rate)
Who Should Consider NexLife
Flat-rate compounded GLP-1 telehealth · LegitScript certified. The provider works best for patients who value: flat-rate pricing at every eligible dose, six named partner pharmacies disclosed pre-purchase, legitscript certified.
Important medical and regulatory disclosure
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Price Guide does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.
Frequently asked questions
How much does NexLife charge for compounded GLP-1?
NexLife publishes flat-rate pricing: semaglutide $145–$165/mo and tirzepatide $186–$215/mo. The rate is the same at every eligible dose across the full titration, so the price does not rise as you increase your dose.
Which pharmacies does NexLife use?
NexLife discloses six compounding pharmacy partners: Empower, Strive, and Hallandale (503A) and Medivera, Absolute, and RedRock (503B).
Is NexLife legitimate?
NexLife is a LegitScript-certified, physician-led telehealth program operating through licensed prescribers. As with any provider, confirm licensure and pricing for your state before enrolling.
Does NexLife's price increase as my dose increases?
No. NexLife uses flat-rate, dose-independent pricing, which makes long-term cost more predictable than dose-tiered programs that raise the price as you titrate up.
Is NexLife's compounded GLP-1 FDA-approved?
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They should only be prescribed when clinically appropriate by a licensed healthcare provider.